Novo Nordisk A/S (NVO) — Technical state
As of 2026-11-13 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: +2.4% at the close — Holding 32.7% off its 52-week high. (as of 2026-11-13)
- Trend: Novo Nordisk A/S trades 3.8% above its 50-day and 2.9% below its 200-day moving average. (as of 2026-11-13)
- Index seat: HALO Growth 100
Novo Nordisk researches, manufactures and distributes pharmaceutical products through two units: Obesity and Diabetes Care, and Rare Disease. The first covers diabetes, obesity, cardiovascular and related conditions, including GLP-1 therapies such as Wegovy alongside insulin pens and dosing apps.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the NVO overview. Research diary readings, not advice.
Holding 32.7% off its 52-week high.
The moving-average stack
- vs 20-day+4.2%
- vs 50-day+3.8%
- vs 200-day-2.9%
- 52-week band32.7% off the high · +20.4% off the low
- Streak1 consecutive up session
- 50-day crossprice crossed up through the 50-day 5 sessions ago
- Stochastic%K 59.9 · %D 57.5 · up cross
Continue: the NVO chart & overview · the earnings record · the signal board
FAQ · from the current data · as of 2026-11-13
Quick answers
What is the current Closelooknet signal on NVO?
+2.4% at the close — Holding 32.7% off its 52-week high. As of 2026-11-13; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is NVO above its 50-day and 200-day moving averages?
As of 2026-11-13, Novo Nordisk A/S trades +3.8% above its 50-day and -2.9% below its 200-day average, with the 20-day +4.2% away.
How far is NVO from its 52-week high?
32.7% below the 52-week high and 20.4% above the 52-week low, as of 2026-11-13.
Mentioned on Closelooknet
Where NVO appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- Midterms — Dow Jumps 2.3% and Apple Hits a Record; Data-Center Power Stocks Sink Up to 15%
Novo Nordisk — outlook raised, shares up 6%
Related in the Closelooknet universe
same Closelooknet index seat first, then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- WISE.L Wise plc
- DECK Deckers Outdoor Corporation
- LLY Eli Lilly and Company
- DXCM DexCom Inc
- TOST Toast Inc
- HDB HDFC Bank Limited ADR
- VRSK Verisk Analytics Inc
- GMED Globus Medical
- IDXX IDEXX Laboratories Inc
- DB1.DE Deutsche Börse AG
- ELF ELF Beauty Inc
- FAST Fastenal Company
- ORNAV.HE Orion Oyj Aindustry
- ORNBV.HE Orion Oyj Bindustry
- SAN.PA Sanofi SAindustry
- AZN.L AstraZeneca PLCindustry
- GSK GSK plcindustry
- AMGN Amgen Incindustry
- SNY Sanofi ADRindustry
- GILD Gilead Sciences Incindustry